National Antimicrobial Stewardship Performance and Antimicrobial Use in Saudi Ministry of Health Hospitals: A Four-Year Multicenter Surveillance Analysis, 2021–2024
Antibiotics · 04.08.2026 · 15 (8) · 753
DOI: 10.3390/antibiotics15080753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 04.08.2026. Verfasst von Saleh Alghamdi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Baha University, Al-Baha 65779, Saudi Arabia. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Antimicrobial stewardship programmes (ASPs) are essential for improving antimicrobial use and limiting the emergence of antimicrobial resistance. Although national ASP key performance indicators (KPIs) have been implemented across Saudi Ministry of Health (MOH) hospitals, large-scale evaluations of programme performance remain limited. This study evaluated national ASP performance across MOH hospitals from 2021 to 2024 using formal KPIs and complementary stewardship measures.
Methods
This retrospective multicentre surveillance analysis included 124,452 antimicrobial prescription reviews from 96 Saudi MOH hospitals actively reporting stewardship activities. Hospitals were classified according to ASP capacity as category A, B, or C. The evaluated KPIs included protocol adherence, restricted-antibiotic dispensing compliance, active intervention rate, annual trends in optimization interventions, and physician acceptance of ASP recommendations. Secondary assessments included appropriateness of therapy management, therapeutic drug monitoring (TDM) for vancomycin and aminoglycosides, and hospital-level antimicrobial use expressed as defined daily doses per 100 available bed-days. Multivariable logistic regression was used to identify factors associated with guideline non-adherence and physician non-acceptance.
Results
Overall protocol adherence was 87.1%, exceeding the national target of 80%, while the active intervention rate was 64.6%, exceeding the 60% benchmark. Restricted-antibiotic dispensing compliance reached 87.6% but remained below the 100% target. Physician acceptance of ASP recommendations was high at 93.0%, although it did not achieve the national target of 98%. The optimization-intervention KPI was not met because de-escalation, antibiotic discontinuation, and intravenous-to-oral conversion did not demonstrate a sustained annual increase. Appropriate ongoing therapy management was documented in 68.3% of cases with available data, whereas TDM was requested in 44.5% of eligible vancomycin or aminoglycoside cases. Antimicrobial use varied across years and hospital categories, with higher monitored broad-spectrum and reserve-agent use in higher-capacity hospitals. Lower ASP capacity, non-critical care settings, and combination therapy were consistently associated with less favourable stewardship outcomes.
Conclusions
Saudi MOH hospitals actively reporting stewardship activities demonstrated favourable performance in protocol adherence, intervention activity, and physician acceptance. However, persistent gaps in restricted-antibiotic dispensing, optimization interventions, TDM, and inter-hospital variation indicate the need for continued strengthening of ASP infrastructure, monitoring, and feedback systems. Future research should link stewardship indicators with clinical outcomes, antimicrobial resistance trends, and patient safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Baha University, Al-Baha 65779, Saudi Arabia.
- General Administration of Pharmaceutical Care, Ministry of Health, Riyadh 11451, Saudi Arabia.
- Hospital Support Operations Centre, Ministry of Health, Riyadh 11176, Saudi Arabia.
- Department of Pharmaceutical Care, Dammam Medical Complex, Eastern Health Cluster, Dammam 32253, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmaceutical Care, Almikwah Hospital, Al-Baha Health Cluster, Ministry of Health, Al-Baha 65784, Saudi Arabia.
ORCID-Profile: Saleh Alghamdi, Reema Almuraybidh, Ahmed Alghamdi, Abdullah S Alshammari, Bassant Mohamed Barakat, Mohammad A Albanghali
Zitieren
APA
Alghamdi, S., Algarni, M., Mutlaq, A., Almuraybidh, R., Alfardus, N., Aljudaibi, S., Aljaffar, A., Alghamdi, A., Alghamdi, S., Alshammari, A. S., Alzahrani, A. A., Barakat, B. M., & Albanghali, M. A. (2026). National Antimicrobial Stewardship Performance and Antimicrobial Use in Saudi Ministry of Health Hospitals: A Four-Year Multicenter Surveillance Analysis, 2021–2024. Antibiotics, 15(8), 753. https://doi.org/10.3390/antibiotics15080753
Vancouver
Alghamdi S, Algarni M, Mutlaq A, Almuraybidh R, Alfardus N, Aljudaibi S, et al. National Antimicrobial Stewardship Performance and Antimicrobial Use in Saudi Ministry of Health Hospitals: A Four-Year Multicenter Surveillance Analysis, 2021–2024. Antibiotics. 2026;15(8):753. doi:10.3390/antibiotics15080753
BibTeX
@article{Alghamdi2026,
author = {Alghamdi, Saleh and Algarni, Mohammad and Mutlaq, Alaa and Almuraybidh, Reema and Alfardus, Nawal and Aljudaibi, Sumaiah and Aljaffar, Amnah and Alghamdi, Ahmed and Alghamdi, Salman and Alshammari, Abdullah S and Alzahrani, Abdulhakim A and Barakat, Bassant Mohamed and Albanghali, Mohammad A},
title = {National Antimicrobial Stewardship Performance and Antimicrobial Use in Saudi Ministry of Health Hospitals: A Four-Year Multicenter Surveillance Analysis, 2021–2024},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {8},
pages = {753},
doi = {10.3390/antibiotics15080753}
}
EUVIMED